EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Comprehensive Analysis of the First 35 Years of Pediatric Heart Transplantation in Sweden

Oscar van der Have iD, Håkan Wåhlander iD, Tove Hofbard iD, Dace Abele iD, Maria Sjöborg Alpman iD, Ilse Duus Weinreich iD, Jens Böhmer iD, Johan Nilsson iD, Jan Holgersson iD, Ann-Sofie Liedberg iD, Karin Tran-Lundmark iD, Michal Odermarsky iD

Pediatric Transplantation · 2025

DOI: 10.1111/petr.70154 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Transplantation, 2025. Verfasst von Oscar van der Have und 11 weiteren Autor:innen. Beteiligte Einrichtung: The Pediatric Heart Center, Skåne University Hospital, Lund, Sweden. Hauptthemen laut MEDLINE: Heart Transplantation, Heart Failure. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Hjärt-Lungfonden, Skåne County Council's Research and Development Foundation, Knut och Alice Wallenbergs Stiftelse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The first 35 years of pediatric heart transplantation (pHTx) in Sweden were investigated to determine outcomes following listing and transplantation, investigate sub‐populations of recipients, and describe the presence of donor‐specific antibodies (DSA) in a contemporary cohort.

Methods

Swedish children < 18 years, listed from 1/1/1989 to 31/12/2023, were included. The cohort was split based on the era of transplantation (ERA I: 1989–2008, ERA II: 2009–2023).

Results

A total of 254 children were listed and 185 (72.8%) reached pHTx, with no loss to follow‐up. Waiting list duration was 62 days and increased over time, while mortality on the waiting list decreased (30.5% in ERA I, 8.8% in ERA II). Congenital heart disease was the etiology of heart failure in 36.2% of recipients, including 24.9% with univentricular physiology. The frequency of ABO‐incompatible transplantations was 9.3% and 8.0% were considered to be at high immunological risk pre‐pHTx due to pre‐formed HLA‐antibodies with mean fluorescence intensity ≥ 5000. Ventricular assist device (VAD) was used in 26.9% of recipients. Long‐term survival was not affected by age, heart failure etiology, the use of pre‐transplant VAD, or elevated baseline indexed pulmonary vascular resistance. Era of transplantation was a determinant of listing, but not post‐pHTx outcome. Survival at 1‐, 10‐, and 30‐year follow‐up was 94.5%, 79.4%, and 57.1%, respectively. Of the total de novo DSA burden, 45.9% were HLA‐DQ‐type specific. Re‐transplantation was performed in 5.9% of recipients.

Conclusions

A high quality of care has been achieved in Sweden, despite modest pHTx numbers, in cooperation with the Scandiatransplant organization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart TransplantationHeart FailureHumansSwedenChildChild, PreschoolMaleInfantFemaleAdolescentWaiting ListsTreatment OutcomeFollow-Up StudiesInfant, NewbornHLA AntigensHeart-Assist DevicesRetrospective StudiesHeart Defects, Congenital

Stichwörter der Autor:innen

donor‐specific antibodiesend‐stage heart failureera‐dependent analysispediatric heart transplantationpulmonary vascular resistance

Substanzen

HLA Antigens

Autor:innen und Institutionen

  • The Pediatric Heart Center, Skåne University Hospital, Lund, Sweden.
  • The Department of Experimental Medical Science and the Wallenberg Center for Molecular Medicine, Lund University, Lund, Sweden.
  • The Pediatric Heart Center, The Queen Silvia Children's Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Department of Clinical Immunology and Transfusion Medicine, Skåne University Hospital, Lund, Sweden.
  • Department of Laboratory Medicine, Institute of Biomedicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

ORCID-Profile: Oscar van der Have, Håkan Wåhlander, Tove Hofbard, Dace Abele, Maria Sjöborg Alpman, Ilse Duus Weinreich, Jens Böhmer, Johan Nilsson, Jan Holgersson, Ann-Sofie Liedberg, Karin Tran-Lundmark, Michal Odermarsky

Förderung

  • Hjärt-Lungfonden
  • Skåne County Council's Research and Development Foundation
  • Knut och Alice Wallenbergs Stiftelse
  • Vetenskapsrådet
  • Fund for Transplant Research, Skåne University Hospital

Zitieren

APA

van der Have, O., Wåhlander, H., Hofbard, T., Abele, D., Alpman, M. S., Weinreich, I. D., Böhmer, J., Nilsson, J., Holgersson, J., Liedberg, A. S., Tran-Lundmark, K., & Odermarsky, M. (2025). Comprehensive Analysis of the First 35 Years of Pediatric Heart Transplantation in Sweden. Pediatric Transplantation. https://doi.org/10.1111/petr.70154

Vancouver

van der Have O, Wåhlander H, Hofbard T, Abele D, Alpman MS, Weinreich ID, et al. Comprehensive Analysis of the First 35 Years of Pediatric Heart Transplantation in Sweden. Pediatric Transplantation. 2025. doi:10.1111/petr.70154

BibTeX
@article{vanderHave2025,
  author = {van der Have, Oscar and Wåhlander, Håkan and Hofbard, Tove and Abele, Dace and Alpman, Maria Sjöborg and Weinreich, Ilse Duus and Böhmer, Jens and Nilsson, Johan and Holgersson, Jan and Liedberg, Ann-Sofie and Tran-Lundmark, Karin and Odermarsky, Michal},
  title = {Comprehensive Analysis of the First 35 Years of Pediatric Heart Transplantation in Sweden},
  journal = {Pediatric Transplantation},
  year = {2025},
  doi = {10.1111/petr.70154}
}
Kostenlos starten →